Compare LFMD & SSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LFMD | SSSS |
|---|---|---|
| Founded | 1994 | 2010 |
| Country | United States | United States |
| Employees | 384 | N/A |
| Industry | Medical/Nursing Services | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.7M | 233.4M |
| IPO Year | N/A | N/A |
| Metric | LFMD | SSSS |
|---|---|---|
| Price | $4.76 | $13.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $9.14 | ★ $15.67 |
| AVG Volume (30 Days) | ★ 1.3M | 308.6K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 7.61% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.52 | N/A |
| Revenue Next Year | $18.73 | $42.86 |
| P/E Ratio | ★ N/A | $3.61 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.60 | $5.75 |
| 52 Week High | $15.34 | $14.48 |
| Indicator | LFMD | SSSS |
|---|---|---|
| Relative Strength Index (RSI) | 56.22 | 56.22 |
| Support Level | $3.39 | $12.82 |
| Resistance Level | $4.93 | $13.66 |
| Average True Range (ATR) | 0.36 | 0.54 |
| MACD | -0.00 | -0.10 |
| Stochastic Oscillator | 47.16 | 25.30 |
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.